Mildronate for Acute Ischemic Stroke

Completed

Phase 2 Results N/A

Summary of Purpose

Mildronate an inhibitor of carnitine-dependent metabolism, is considered an anti-ischemic drug. This study aims to evaluate the efficacy and safety of mildronate injection in treating acute ischemic stroke.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 10 April 2013.

1 Jul 2008 10 Apr 2013 1 Apr 2010 1 Apr 2010 1 Apr 2013 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment

Contacts

Not available